Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 103 | BSPED2024 | Next issue

51st Annual Meeting of the British Society for Paediatric Endocrinology and Diabetes

Glasgow, UK
08 Oct 2024 - 10 Oct 2024

Card image cap
The 51st Annual BSPED Meeting will take place at the Hilton Hotel, Glasgow from Tuesday 8 – Thursday 10 October 2024.

Oral Communications

Endocrine Oral Communications 4

ea0103oc10.1 | Endocrine Oral Communications 4 | BSPED2024

Health-related quality of life in severe obesity: baseline PedsQL scores from two tier 3 paediatric weight management services

Hawton Katherine , Apperley Louise , Canvin Lauren , Parkinson Jennifer , Owens Meghan , Semple Claire , Holt Alanna , Easter Shelley , Clark Kate , Ramakrishnan Anand , Gokul Ramya , Clarke Ellie , O'Brien James , Giri Dinesh , Senniappan Senthil , Hamilton-Shield Julian

Background: Paediatric Quality of Life Inventory 4.0 (PedsQL) is a 23-item questionnaire completed by children and young people (CYP) and parents/carers, to measure health-related quality of life (HRQoL). It comprises four domains (Physical, Emotional, Social, School Functioning) and is scored 0-100, with higher scores indicating better HRQoL. We report baseline PedsQL scores of CYP living with severe obesity under the care of two, tier 3 Complications of Excess Wei...

ea0103oc10.2 | Endocrine Oral Communications 4 | BSPED2024

The effect of lifestyle and pharmacological interventions on body composition in childhood obesity

Dixon Hannah , Apperley Louise , Senniappan Senthil , Parkinson Jennifer

Introduction: Children and adolescents with a body mass index (BMI) greater than the 98th centile are at an increased risk of complications including cardiovascular and liver disease and type 2 diabetes mellitus. Currently, lifestyle modification is the first line intervention. Pharmacotherapy, such as liraglutide and semaglutide, has recently been licensed for adolescents greater than 12 years of age. This study aimed to compare the impact of pharmacotherapy and lifestyle mod...

ea0103oc10.3 | Endocrine Oral Communications 4 | BSPED2024

Increased prevalence of hypertension in paediatric turner syndrome

Sutherland Aimee , Lucas-Herald Angela , Mason Avril

Introduction: Turner syndrome (TS) is a chromosomal disorder characterised by an abnormality of or a partial or complete absence of one of the X chromosomes in a phenotypic female. The TS population experience aortic dissection at a rate ten times that of the general population, for which hypertension is a modifiable risk factor. Our primary aim was to determine the frequency of hypertension in girls attending a tertiary paediatric dedicated TS clinic in the West of Scotland a...

ea0103oc10.4 | Endocrine Oral Communications 4 | BSPED2024

Education of sick day management of paediatric adrenal insufficiency: a national survey of paediatric endocrine nurse specialists

Bradford Anna , McKechnie Jennifer , AbdelRahman Shima , Mushtaq Talat , Ng SM , Tollerfield Sally , Laing Peter , Wong SC

Background and aims: A critical component of adrenal insufficiency (AI) management is education for the family and young person regarding sick day episode management. Deficits in patient education have been identified to contribute to adrenal crisis risk. The aim of this online survey distributed via the British Society for Paediatric Endocrinology (BSPED) paediatric endocrine nurse specialists (PENS) mailing list is to identify current clinical practice regarding education in...

ea0103oc10.5 | Endocrine Oral Communications 4 | BSPED2024

Single-centre review of use of gonadotrophin-releasing hormone agonists – are we outliers?

Thomas David , Woodhouse Amy , Wood Claire , Howard Sasha , Elder Charlotte

Background: Gonadotrophin-Releasing Hormone agonists (GnRHa) are the mainstay of treatment for central precocious puberty (CPP). The long-acting formulation, Decapeptyl SR (Triptorelin pamoate), is commonly used, given as an 11.25 mg intramuscular injection 12-weekly. Recently, a 24-weekly, 22.5 mg preparation, has been introduced with reduced numbers of injections offering cost and patient benefits. Results of a two-centre UK study demonstrated no significant difference in ef...

ea0103oc10.6 | Endocrine Oral Communications 4 | BSPED2024

Audit of pituitary dysfunction post moderate to severe traumatic brain injury and proposed surveillance guidance

McBay-Doherty Rhiannon , Stevenson Kim , McCusker Caroline , Flanagan Catherine , Abid Noina

Background: A recent case of a seven-year-old boy developing diabetes insipidus, central hypothyroidism and growth hormone deficiency following a severe traumatic brain injury (TBI) highlighted a lack of surveillance for post-TBI pituitary dysfunction within the tertiary paediatric hospital of Northern Ireland. There are limited paediatric studies into this area, but evidence suggests post-TBI hypopituitarism occurs fairly frequently in children; with prevalence of isolated ho...